The evolution of the management of GRT

Article

During the advent of surgical approaches for retinal detachment repair, one of the most challenging cases a retinal surgeon may come across was a giant retinal tear. This article summarizes the history of GRT management and discusses current trends in surgical management.

The management of GRTs has evolved considerably over the decades. Early surgical techniques such as intraocular balloons (1970s), rotating tables and retinal incarceration with tacks, sutures and screws (1980s) have evolved into small gauge pars plana vitrectomy (PPV), wide field viewing systems and intraoperative perfluorocarbon liquid (PFCL) use. This article will briefly summarize the history of GRT management and discuss current trends in surgical management.

History of GRT management

Success rates in the management of GRTs are associated with the ability of the surgeon to manipulate the retinal flap back into its original configuration and maintain its position with intraoperative and postoperative tamponade. Earlier attempts were limited by an inability to effectively achieve and maintain the proper position of the retinal flap. A primary encircling scleral buckle could be successful in cases of minimally displaced GRTs with the placement of a low broad based scleral buckle. In the early 1980s, with the evolution of vitrectomy techniques, the surgeon could manipulate the GRT intraoperatively with rotating tables and intraocular gas tamponade.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2025 MJH Life Sciences

All rights reserved.